Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2577-2578
doi: 10.1161/01.ATV.0000242795.08322.fb
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alessandri, C.
Right arrow Articles by Violi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alessandri, C.
Right arrow Articles by Violi, F.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2577.)
© 2006 American Heart Association, Inc.


Letters to the Editor

Alpha-Linolenic Acid–Rich Wheat Germ Oil Decreases Oxidative Stress and CD40 Ligand in Patients With Mild Hypercholesterolemia

Cesare Alessandri; Pasquale Pignatelli; Lorenzo Loffredo; Luisa Lenti; Maria Del Ben; Roberto Carnevale; Alessandro Perrone; Domenico Ferro; Francesco Angelico; Francesco Violi

From the Department of Experimental Medicine and Pathology, IV Clinical Division, Università di Roma "La Sapienza", Rome, Italy.

Correspondence to Prof Francesco Violi, Divisione IV Clinica Medica, University "La Sapienza", Viale del Policlinico 161, 00185 Rome, Italy. E-mail francesco.violi@uniroma1.it


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Epidemiological studies have underlined that a higher intake of {alpha}-linolenic acid (18:3n-3) is inversely associated with coronary and carotid atherosclerotic disease.1 Long-chain n-3 fatty acids have been suggested to delay the atherosclerotic process through an antiinflammatory activity2 and in turn to stabilize vulnerable plaque.3 Previous studies suggested, in particular, that n-3 fatty acids may exert an antiinflammatory action by reducing oxidative stress.4 As we have previously shown that oxidative stress is implicated in upregulating CD40 ligand (CD40L), a protein with inflammatory and prothrombotic property,5,6 we tested the hypothesis that 18:3n-3 may protect against atherosclerotic disease also via inhibiting oxidative stress–mediated CD40L expression. To investigate this issue, 32 patients with hypercholesterolemia were randomly allocated, in a double blind fashion, to 2 months supplementation with 2 vegetable oils (1 tbsp/d) containing low (maize oil, 0.63%) or high (wheat germ oil, 8.6%) percentage of 18:3n-3. Before and after treatment oxidative stress and CD40L, a protein that is implicated in the progression of atherosclerotic disease,5 were measured. Also, we analyzed in vitro whether 18:3n-3 fatty acids were able to influence platelet oxidative stress and CD40L expression (for expanded Methods, see supplementary data available online at http://atvb.ahajournals.org).

There were no differences in clinical and laboratory characteristics between the 2 groups; after supplementation with both vegetable oils, no change of serum lipid profile was observed (not shown).

Maize oil supplementation did not change either soluble CD40 Ligand (sCD40L) data or 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative stress7 (not shown). Conversely, a parallel (r=0.534; P. . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
P. Pignatelli, R. Cangemi, A. Celestini, R. Carnevale, L. Polimeni, A. Martini, D. Ferro, L. Loffredo, and F. Violi
Tumour necrosis factor {alpha} upregulates platelet CD40L in patients with heart failure
Cardiovasc Res, June 1, 2008; 78(3): 515 - 522.
[Abstract] [Full Text] [PDF]